GRα could be bound and activated by glucocorticoids, and previous studies have shown that a higher expression of glucocorticoids receptors has been correlated with a better prognosis in bladder cancer (Ishiguro et al., 2014; Zheng et al., 2012). Here, NR3C1 is linked to urinary bladder carcinoma.